SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Janssen Research & Development Release: Crohn's Disease Patients Refractory to Tumor Necrosis Factor Inhibitors Showed Improvement in Disease With STELARA® Treatment
Your Message